Clinical Trials

Microwave ablation for cancer

Displaying 4 studies

Study of the NEUWAVE Flex Microwave Ablation System in the Ablation of Primary Soft Tissue Lesions of the Lung Rochester, MN

Patients with medically inoperable primary soft tissue lesion of the lung will have transbronchial microwave ablation performed via transbronchial approach by an interventional pulmonologist or thoracic surgeon using CT imaging. Prior to the ablation procedure, the treating physician will use endobronchial ultrasound to confirm staging. Patients will be followed for one year following the ablation procedure for efficacy and safety.
MARK 1A Series: Percutaneous Microwave Ablation for Patients With Lung Tumor(s) No Locations

The purpose of this study is to evaluate if lung ablation improves clinical outcomes for patients deemed to be surgically high-risk.
A Study to Assess the BioTraceIO System for Identifying Tissue Damage from Microwave Thermal Liver Ablation Scottsdale/Phoenix, AZ

The purpose of this study is to evaluate the accuracy of the BioTrace IO during RFA/MWA Transcutaneous procedures.
Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) Rochester, MN

The purpose of this study is to demonstrate that microwave ablation (MWA) of up to 3 hepatic metastases, each with a maximum diameter of ≤ 2.5 cm will result in a 2-year local progression free survival of at least 90%. This is a standard of care (SOC) study.